Kidney International Reports

Papers
(The median citation count of Kidney International Reports is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Association Between Maternal Smoking, Isolated Proteinuria During Pregnancy and Preterm Birth: A Finnish Registry Analysis193
Nephrologists’ Views on a Workflow for Returning Genetic Results to Research Participants178
Anti-Rituximab Antibodies in Primary Membranous Nephropathy: Time for Routine Monitoring in Clinical Practice?136
Navigating Complex Relationships Between Perioperative Hypotension and Delayed Graft Function in Kidney Transplantation109
Association of Pulmonary Hypertension With Outcomes in Kidney Transplant Recipients91
Addressing the Multisystemic Impacts of Nephropathic Cystinosis in an Adult88
WCN24-2180 The beneficial effects of ω3-PUFA on renal fibrosis via AMPK-mediated autophagy flux82
WCN24-1742 TOTALLY HARMLESS OR SLOW BURN: HOW DO WE INTERPRET CHANGES IN SERUM CREATININE FROM MOLECULARLY-TARGETED CANCER THERAPIES?81
WCN24-1498 CHARACTERISTICS OF ADMISSION TO HEMODIALYSIS OF THE PATIENT WITH CHRONIC KIDNEY DISEASE IN SANTA CRUZ-BOLIVIA: A DESCRIPTIVE AND ANALYTICAL OBSERVATIONAL MULTICENTER CROSS-SECTIONAL STUDY81
WCN24-2225 COMPARISON OF HANDHELD VERSUS HIGH-END ULTRASOUND DEVICES FOR THE GUIDANCE OF PERCUTANEOUS KIDNEY BIOPSY70
WCN24-707 QUALITY OF LIFE IN HEMODIALYSIS PATIENTS IN BOLIVIA67
WCN24-2081 ATYPICAL MANIFESTATION OF TUBERCULOSIS IN HEMODIALYSIS65
WCN24-2446 EVALUATION OF DISEASE MANAGEMENT AND SELF-CARE NEEDS IN INDIVIDUALS WITH CHRONIC KIDNEY DISEASE65
WCN24-1671 THE METABOLIC VULNERABILITY INDEX, REFLECTING MALNUTRITION AND INFLAMMATION, PREDICTS MORTALITY IN KIDNEY TRANSPLANT RECIPIENTS63
WCN24-594 REMOTE MONITORING: WHAT REALLY HAPPENS DURING PERITONEAL DIALYSIS?63
WCN24-1112 ASSESSMENT AND COMPARISON OF THE QUALITY OF LIFE OF BRAZILIAN AND VENEZUELAN PATIENTS WITH CHRONIC KIDNEY DISEASE UNDERGOING HEMODIALYSIS TREATMENT IN RORAIMA-BRAZIL59
WCN24-2671 ORCHESTRA (Korean dialysis cohort for mineral, vascular calcification, and fracture) Study: Design, method, and baseline characteristics57
WCN24-2404 THROMBOTIC MICROANGIOPATHY AS CAUSE OF RENAL GRAFT DYSFUNCTION IN PATIENT WITH ANTIPHOSPHOLIPID ANTIBODY SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS AND RESPONSE TO B-CELL ACTIVATING FACTOR I54
WCN24-2452 A STUDY OF CLINICAL PROFILE AND OUTCOME OF PREGNANCY RELATED ACUTE KIDNEY INJURY IN A TERTIARY CARE CENTER IN SOUTH INDIA53
WCN24-2135 CONGENITAL ANOMALIES OF THE KIDNEY AND URINARY TRACT IN CHILDREN IN TWO HOSPITALS IN DOUALA CAMEROON53
WCN24-741 LONG-TERM OUTCOMES OF RENAL TRANSPLANTATION IN CHILDREN WEIGHING LESS THAN 10 KG52
WCN24-1234 RENAL TUBULE-SPECIFIC NRF2 DELETION ATTENUATES GLOMERULAR HYPERFILTRATION AND KIDNEY INJURY VIA DOWN-REGULATION OF SGLT2 AND ANGIOTENSINOGEN EXPRESSION IN DIABETIC MICE50
WCN24-797 Roles of Irisin, a myokine on uremic sarcopenia49
WCN24-295 COVID-19 AND ACUTE KIDNEY INJURY IN ELDERLY PATIENTS: COMPARATIVE COHORT STUDY BETWEEN THE FIRST AND SECOND WAVES OF THE PANDEMIC IN BRAZIL49
WCN24-2576 ENHACING SAFETY IN TUNNELED HEMODIALYSIS CATHETER INSERTION WITH NON-FLUOROSCOPIC TECHNIQUES48
WCN24-1041 OXIRIS MEMBRANE PERFORMANCE IN PATIENTS WITH SEPTIC SHOCK AND CONTINUOUS KIDNEY REPLACEMENT THERAPY REQUIREMENT: A RANDOMIZED CONTROLLED TRIAL47
WCN24-2440 A PROSPECTIVE STUDY OF ROLE OF" DOUBLE J STENTING" IN UROSEPSIS, PROGRESSING TO SEVERE SEPPSIS IN A TERITIARY CARE CENTER IN RURAL INDIA47
WCN24-2260 A RANDOMIZED CONTROLLED TRIAL OF ALLOPURINOL FOR CVD IN CKD: STUDY POPULATION CHARACTERISTICS45
WCN24-1211 To determine the effectiveness of Lactoferrin in improving Anemia in iron replete CKD patients44
WCN24-496 THE SIGNIFICANCE OF DETERMINING IMMUNO-NUTRITIONAL INDEXES IN THE ASSESSMENT OF LUPUS NEPHRITIS ACTIVITY41
WCN25-2239 QUANTITATIVE IMAGE ANALYSIS UNCOVERS THE EFFICACY OF THE SELECTIVE ENDOTHELIN A RECEPTOR ANTAGONIST ATRASENTAN IN A RAT MODEL OF IGA NEPHROPATHY41
WCN25-992 STRATEGIES TO DECREASE HEPATITIS C BURDEN AND IMPROVE SAFETY, COST-EFFECTIVELY IN THE HEALTH SYSTEM AMONG PATIENTS ON HEMODIALYSIS: LESSONS FROM LOW RESOURCE SETTINGS41
WCN25-1290 A FATAL CASE OF AV FISTULA THROMBOSIS ASSOCIATED WITH PULMONARY THROMBOEMBOLISM IN POST RENAL TRANSPLANT PATIENT40
WCN25-3057 Environmentally Informed Prescribing in Kidney Care: An environmental impact scan of a provincial kidney formulary40
WCN25-3072 CLINICAL FEATURES OF 7 PATIENTS UNDER HEMODIALYSIS FOR MORE THAN 20 YEARS IN THE DIALYSIS UNIT OF THE UNIVERSITY HOSPITAL CENTRE OF SAHLOUL37
WCN25-1583 PREVALENCE AND RISK FACTORS OF INTRADIALYTIC HYPERTENSION IN MALAYSIAN HAEMODIALYSIS PATIENTS: A MUTLI-CENTRE OBSERVATIONAL STUDY37
WCN25-1449 FAMILIAL IGA NEPHROPATHY: A PERPLEXING CONUNDRUM IN A FAMILY37
WCN25-4542 Virtual Care is a barrier to sustaining trusting relationships and optimal clinical outcomes for Peritoneal Dialysis patients from Rural and Indigenous Communities35
WCN25-414 EFFECT OF STRUCTURED NUTRITIONAL EDUCATION ON SUBJECTIVE GLOBAL ASSESSMENT SCORES IN HAEMODIALYSIS PATIENTS: A SINGLE CENTRE –PROSPECTIVE OBSERVATIONAL STUDY35
WCN25-967 REGULAR USE OF TACROLIMUS GENOTYPE TEST AND USE OF FLUCONAZOLE IN FAST METABOLIZERS TO ACHIVE THERAPEUTIC DRUG LEVELS POST KIDNET TRANSPLANTATION35
WCN25-3972 THE SILENT THREAT: CAN BATTERIES DISCHARGE YOUR KIDNEYS? – A CASE REPORT ON AKI DUE TO OCCUPATIONAL EXPOSURE34
WCN25-1896 ONE YEAR OUTCOMES OF KIDNEY TRANSPLANT RECIPIENTS IN ZAMBIA - SUBSAHARAN AFRICA34
WCN25-4221 DEMOGRAPHY AND PRACTICE PATTERN OF END STAGE RENAL DISEASE IN KERALA,INDIA-REPORT FROM TRIVANDRUM DIALYSIS REGISTRY BY TRIVANDRUM NEPHROLOGY CLUB34
WCN25-4456 GLOMERULOCYSTIC KIDNEY DISEASE: KEY INSIGHTS AND LESSONS LEARNED34
WCN25-1020 Nephrology as the leader in Point of Care Ultrasound (POCUS)33
WCN25-3847 AN UNUSUAL CASE OF HSV PNEUMONIA MASQUERADING AS PCP PNEUMONIA IN POST TRANSPLANT PATIENT32
WCN25-643 THE LIFESAVING JOURNEY FOR CALCIPHYLAXIS: ADDRESSING RAPIDLY PROGRESSIVE ATTACKS WITH MULTIDIMENSIONAL AND AI RESEARCH FOR REGENERATIVE MEDICINE32
WCN25-4606 DIAGNOSTIC UTILITY AND CLINICAL IMPACT OF GENOMIC TESTING NI ADOLESCENT AND ADULT KIDNEY DISEASE PATIENTS WITH SUSPECTED MONOGENIC ETIOLOGY – A PRAGMATIC PROSPECTIVE OBSERVATIONAL COHORT ST31
WCN25-2982 USG guided needle directed thrombolysis of acute AVF thrombosis: A Case Series31
WCN25-3276 SPECTRUM OF KIDNEY DISEASES IN ADOLESCENT POPULATION: A SINGLE-CENTER STUDY31
WCN25-4220 CAPD IN ESRD AND CLD PATIENTS WITH REFRACTORY ASCITES: A 12-MONTH FOLLOW-UP STUDY31
WCN25-2130 A STUDY TO CORRELATE SERUM PHOSPHORUS WITH MARKER OF ENDOTHELIAL CELL DYSFUNCTION IN CHRONIC KIDNEY DISEASE PATIENTS ON MAINTENANCE HAEMODIALYSIS31
WCN25-4378 OUTCOME OF USE OF ENTERIC RELEASED BUDESONIDE IN IgA NEPHROPATHY PATIENTS WITH NEPHROTIC AND SUBNEPHROTIC PROTEINURIA PRESENTATIONS: PROSPECTIVE COMPARATIVE STUDY IN TERTIARY CARE CENTRE30
WCN25-2785 UNMET MENTAL HEALTH NEEDS AND CAREGIVER STRAIN IN CONTINUOUS AMBULATORY PERITONEAL DIALYSIS30
WCN25-989 Challenges and Opportunities in Assessing Kidney Function in Simultaneous Heart-Kidney Transplant Candidates30
WCN25-1541 Comparing the Accuracy of Overhydration Assessment Methods in Hemodialysis and Peritoneal Dialysis Patients: The Potential Future of Wearable BIA Device30
WCN25-2084 EVALUATION OF TUBULOGLOMERULAR OUTCOME BY MEASURING PROTEINURIA AND URINARY NGAL AFTER INDUCTION BY MMF IN CLASS III/IV LUPUS NEPHRITIS29
Coronaries, Calcium, and Kidney Consequences29
WCN25-2338 POTENTIAL DIAGNOSTIC ROLE OF URINARY EXOSOMAL miRNAS IN IgA NEPHROPATHY: A CLINICAL OBSERVATIONAL STUDY28
WCN25-3017 IMMUNOSUPPRESSION COMBINED WITH TONSILLECTOMY IS EFFECTIVE IN CAUCASIAN PATIENTS WITH HIGH-RISK PRIMARY IGA-NEPHROPATHY28
WCN25-128 SECONDARY HYPERPARATHYROIDISM IN DIALYSIS PATIENTS: SHORT- AND LONG-TERM OUTCOMES OF CONSERVATIVE PARATHYROIDECTOMY28
WCN25-1435 VISUALIZATION OF THE MESANGIAL-CELL-SURFACE AUTOANTIGENS IN IGA NEPHROPATHY27
Pregnancy and Family Planning in Women With Kidney Disease27
WCN25-3004 ANTi-NEPHRIN ANTIBODIES IN A LARGE COHORT OF PATIENTS WITH IDIOPATHIC NEPHROTIC SYNDROME27
Feasibility of DNA-Based Diagnosis of Fibrinogen A Alpha-Chain Amyloidosis From Paraffin-Embedded Kidney Tissue27
Risks, Diagnostic Thresholds, and Outcomes of Pediatric CKD in Rural Africa27
Vasopressin for Post-kidney Transplant Hypotension27
Depressive Symptoms at Kidney Transplant Evaluation and Access to the Kidney Transplant Waitlist27
POS-014 NEPHROLOGY REFERRAL PATTERN AND SHORT-TERM OUTCOMES IN COVID 19 POSITIVE PATIENTS26
Droxidopa for Management of Chronic Hypotension in Hemodialysis26
POS-072 HEMODIALYSIS TUNNELED-CATHETER RELATED INFECTIONS: RETROSPECTIVE STUDY IN PUBLIC CENTER OF DAKAR (2017-2020)26
POS-084 OUTCOMES OF BIOPSY PROVEN BKV NEPHROPATHY POST KIDNEY TRANSPLANT – A SINGLE CENTRE EXPERIENCE26
POS-065 DISSEMINATED TUBERCULOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS: A RARE PRESENTATION AS A PULMONARY-RENAL SYNDROME26
Program Implementation to Achieve Sustainability for Early Detecting of Kidney Diseases and Promoting Kidney Health and Transplantation in Communities26
SARS-CoV-2 Infection Evolution Among Nephrologists During the Pandemic: Clinical Features and Impact of Vaccination25
Response to: “Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control Study”25
Epigenome-Wide Association Studies of DNA Methylation in Kidney Diseases25
POS-036 A YOUNG FEMALE WITH RENAL CORTICAL NECROSIS TREATED WITH INTRAVENOUS IMMUNOGLOBULIN IN A RESOURCE POOR SETTING: CASE REPORT25
POS-018 PHASE CONTRAST MAGNETIC RESONANCE IMAGING TO ASSESS RENAL PERFUSION IN PATIENTS WITH C3 GLOMERULOPATHY OR IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS25
POS-133 CASE REPORT OF DISSEMINATED KLEBSIELLA INFECTION IN T2DM LEADING TO CKD25
POS-074 Recurrent subcutaneous Phaeohyphomycosis with bone involvement after kidney transplant: A case report25
WCN23-1177 Practice patterns of Chronic Kidney Disease Screening and Monitoring in Brazil: A Nationwide Laboratory-based Analysis25
WCN23-1039 THE XGBckd MODEL: PREDICT CHRONIC KIDNEY DISEASE IN DIABETES PATIENTS24
WCN23-0212 LIRAGLUTIDE IMPROVES BOTH DIABETIC NEPHROPATHY AND CARDIOMYOPATHY IN THE SDT FATTY RAT, A CARDIORENAL MODEL OF TYPE 2 DIABETES24
WCN23-0435 UREMIC PERICARDITIS IN CHRONIC END-STAGE RENAL DISEASE: EXPERIENCE OF THE IBN ROCHD UNIVERSITY HOSPITAL24
WCN23-0285 Acute Kidney Disease in the Outpatient Setting: A Hidden Burden Detected by the Integrated National and Institutional Electronic Medical Records Exchange Platform24
WCN23-0687 CHANGES OF MEDICAL COSTS AND NUMBER OF USES FOR CONTINUOUS RENAL REPLACEMENT THERAPY UNTIL RECENT SIX YEARS IN SOUTH KOREA24
WCN23-0334 VITAMIN D LEVEL IN SLE PATIENTS WITH OR WITHOUT RENAL INVOLVEMENT AND IT’S RELATIONSHIP WITH DISEASE ACTIVITY (SLEDAI SCORE)24
WCN23-0373 ALTERNATIVE COMPLEMENT PATHWAY PHARMACODYNAMICS OF IPTACOPAN24
WCN23-0377 THE ROLE OF INTRA-CATHETER TAUROLIDINE IN PREVENTING RELAPSING AND REPEAT PERITONEAL DIALYSIS-RELATED PERITONITIS24
WCN23-0258 SHORT-CHAIN FATTY ACIDS DIRECTLY EXERT ANTI-INFLAMMATORY RESPONSES IN PODOCYTES AND TUBULAR EPITHELIAL CELLS EXPOSED TO HIGH GLUCOSE24
WCN23-0567 PERTURBATIONS IN FREQUENCY AND FUNCTION OF CLASSICAL AND EXHAUSTED MEMORY B CELLS IN LUPUS NEPHRITIS24
WCN23-1059 OUTCOME OF ATYPICAL HEMOLYTIC UREMIC SYNDROME IN ADULT : A SINGLE CENTER STUDY IN TAIWAN23
WCN23-0595 A MIN-TERM CLINICAL FOLLOW-UP STUDY ON CREATING ARTEIOVENOUS FISTULA BY A MODIFIED NO-TOUCH TECHNIQUE23
WCN23-0378 STUDY OF CLINICAL OUTCOME AND FOLLOW-UP OF MALE LUPUS NEPHRITIS IN A TERTIARY CARE CENTER23
WCN23-0138 Can a Kidney Failure Patient survive with one to two hemodialysis sessions per month for more than 5 years?23
WCN23-1008 PAEDIATRIC RENAL TRANSPLANTATION : EXPERIENCE OF A CENTER23
WCN23-0582 ECULIZUMAB FOR BEVACIZUMAB-INDUCED THROMBOTIC MICROANGIOPATHY23
WCN23-0355 A SEASON OF ACUTE KIDNEY INJURY POST BREAST AUGMENTATION23
WCN23-0525 A new therapeutic strategy in severe IgA nephropathy by MP pulse and SVF23
WCN23-0894 APPLICATION OF KDQOL SF- V 1.3 IN OLDER PATIENTS WHO MADE PREVALENT HEMODIALYSIS23
WCN23-1106 POLYOMAVIRUS TYPE BK-ASSOCIATED NEPHROPATHY IN A NON-KIDNEY TRANSPLANT RECIPIENT23
WCN23-0120 MEDIUM AND LONG TERM ANTIBODY RESPONSE TO COVID-19 VACCINATION IN PATIENTS RECEIVING HEMODIALYSIS (HD) - A CROSS SECTIONAL STUDY23
WCN23-1170 ASSOCIATION OF ANGIOTENSINOGEN GENE POLYMORPHISM WITH NEPHROPATHY IN TYPE 2 DIABETIC PATIENTS OF BANGLADESH23
WCN23-0726 UREA REDUCTION IN ACUTE KIDNEY INJURY AND MORTALITY RISK23
WCN23-0905 SYSTEMATIC MICROBIOME DYSBIOSIS ARE ASSOCIATED WITH IGA NEPHROPATHY23
WCN26-7827 Acute Kidney Injury/Chronic Kidney Disease diagnosis through Optoelectronic-based urine analysis22
POS-008 EXTRARENAL MANIFESTATIONS OF ATYPICAL HEMOLYTIC UREMIC SYNDROME: CARDIAC AND LUNG INVOLVEMENT22
WCN24-2134 TG/HDL-C ratio as mortality predictor in chronic hemodialysis patients22
All About ABBA: New Insights Into Antibrush Border Antibody Disease22
WCN26-214 Association Between Ankle-Brachial Index and Coronary Artery Calcification Score in Patients Beginning Hemodialysis22
In-Center Hemodialysis and Patient Travel Time in Aotearoa New Zealand: A Nationwide Geospatial and Data Linkage Study22
Inside CKD: Cost-Effectiveness of Multinational Screening for CKD22
WCN26-3845 EVALUATING TIME ZERO BIOPSY FINDINGS AND ONE YEAR KIDNEY FUNCTION IN LIVE DONORS AND RECIPIENTS IN SRI LANKA22
WCN26-4400 INACTIVATING MUTATIONS IN NEDD4L CAUSE LIDDLE SYNDROME WITH NEPHROGENIC-DIABETES-INSIPIDUS AND DEAFNESS (LINDID)22
WCN24-933 Effectiveness and safety of Finerenone in Chinese CKD patients without diabetes mellitus: A real-world retrospective study22
WCN26-6760 Comparative Outcomes of Acute Kidney Injury Before And After Extracorporeal Membrane Oxygenation Initiation: A Retrospective Cohort Study22
WCN26-7152 IMPLANTABLE ARTIFICIAL KIDNEY FOR HYBRID RENAL REPLACEMENT THERAPY22
WCN26-7856 INITIAL HEMATOLOGICAL PARAMETERS AND 28 DAYS MORTALITY IN PATIENTS WITH SEPSIS ASSOCIATED ACUTE KIDNEY INJURY21
WCN26-4001 A Case of Gitelman Syndrome Complicated by Familial Chronic Intestinal Pseudo-Obstruction and Refractory Electrolyte Imbalance21
WCN26-8867 Early detection of Kidney disease risk: Implementation of a Non-Invasive Screening Program21
WCN26-8325 Decision Support System for Renal Replacement Therapy and Comprehensive Patient Support Including End-of-Life Care at Fussa Hospital21
WCN26-1984 PROGNOSTIC FACTORS OF IGA NEPHROPATHY: A SINGLE-CENTER RETROSPECTIVE COHORT STUDY AT OUR INSTITUTION21
WCN26-3966 ULTRA-CLEAN DRINKING WATER: A LIFESAVING INTERVENTION FOR RURAL AGRICULTURAL COMMUNITIES AFFECTED BY THE CKD EPIDEMIC IN SRI LANKA – A SUCCESS STORY21
WCN26-3483 Direct evidence for the spontaneous conversion of residual intact tubules within injured kidney tissue into proinflammatory failed-repair proximal tubular cells21
WCN26-3206 Pixel Array–Based Urine Biosensor for Real-Time Detection of Trimethylamine N-Oxide and Glucose in Early Diabetic Kidney Disease21
WCN26-4276 Gene expression levels of CD40L, OX40L, TNFa, or BTK are inversely related to likelihood of complete remission in patients with FSGS and MCD21
WCN26-4880 Combined Cystatin C– and Creatinine-Based Estimated Glomerular Filtration Rate for Colistin Dosing to Prevent Acute Kidney Injury: Preliminary Results of the COLD-PrevAKI Randomized Control21
WCN26-7260 UNMASKING A SILENT TUBULOPATHY: A HOMOZYGOUS SLC12A3 VARIANT PRESENTING WITH LATE CLINICAL ONSET21
WCN26-8323 Chronic kidney disease in older patients: the contribution of kidney pathology to the estimated glomerular filtration21
WCN26-7605 PATIENT SATISFACTION WITH A PHARMACIST-LED CHRONIC KIDNEY DISEASE SCREENING AND INTERVENTION TRIAL IN AUSTRALIAN COMMUNITY PHARMACIES21
WCN26-4944 Structured Post-Travel Infection Surveillance for Safeguarding Haemodialysis Patients21
WCN26-3627 Modeling Crescentic Glomerulonephritis in Mice via Bovine NC1 Domain of Type IV Collagen: A Low-Mortality Approach21
WCN26-7574 KETONE BODY SUPPLEMENTATION AMELIORATES ADENINE-INDUCED KIDNEY INJURY IN MICE20
WCN26-4420 QUALITY AND SAFETY OF CT-GUIDED NATIVE KIDNEY BIOPSY – A SINGLE CENTER STUDY20
WCN26-2331 CLINICO-EPIDEMIOLOGICAL PATTERNS OF ANCA-ASSOCIATED VASCULITIS IN QUEENSLAND: RURAL DISPARITIES WITHOUT SEASONAL VARIATION20
WCN26-3398 Rebiopsy-Guided Long-term Management and Iptacopan Introduction in a Steroid-Dependent Case of C3 Glomerulopathy with Cyclosporine Nephrotoxicity20
WCN26-6891 Navigating pregnancy with CKD – a quaternary care hospital experience19
WCN26-2827 THE EXPERIENCE OF THE PALLIATIVE CARE IN NEPHROLOGY OUTPATIENT CLINIC AT A HOSPITAL IN MINAS GERAIS - BRAZIL19
WCN26-8707 PLASMA AND URINARY PROTEOMIC PROFILES ASSOCIATED WITH RISK OF DISEASE PROGRESSION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE19
WCN26-4217 EFFECT OF LOW VS NORMAL PROTEIN DIET ON RENAL FUNCTION RESERVE IN STAGE 3&4 CHRONIC KIDNEY DISEASE:LARGEST RANDOMIZED TRIAL FROM SOUTHEAST ASIA18
WCN26-4351 Reduction of circulating EPCs mediates hippocampus damage in rats with chronic renal failure and active vitamin D3 intervention study18
WCN26-5176 ILA Levels Define Divergent Gut Microbiome Networks and Metabolic Profiles18
WCN26-3509 Diuretic-Resistant Congestive Nephropathy Without Heart Failure: Benefit of Small-Volume Hypertonic Saline—A Case Report18
WCN26-4385 CLINICAL PROFILE, ENDOSCOPY AND COLONOSCOPY FINDINGS AS WELL AS PROTON PUMP INHIBITOR USE AMONG FILIPINO CHRONIC KIDNEY DISEASE PATIENTS WITH GASTROINTESTINAL BLEEDING IN NAGA CITY, PHILIPP18
WCN26-3758 PROGNOSTIC IMPACT OF RENAL MEDULLARY PATHOLOGY ON KIDNEY OUTCOMES18
WCN26-3821 THE IMPACT OF PHYSICAL TRAINING ON THE PROGRESSION OF DIABETIC KIDNEY DISEASE IN NICOTINE-EXPOSED RATS18
WCN26-6459 FROM ISCHAEMIA TO HEALING: SUCCESSFUL MULTIMODAL MANAGEMENT OF PENILE CALCIPHYLAXIS IN KIDNEY FAILURE18
WCN26-7684 Assessment of Frailty and Clinical Outcomes in Elderly Patients with Acute Kidney Injury: Case Series Analysis Using FRAIL scale18
WCN26-1765 Successful hemodialysis catheter placement into a stenosed femoral vein using balloon dilation for central venous access18
WCN26-2323 GUT MICROBOTA OF HEMODIALYSIS PATIENTS PRODUCCES HIGH LEVELS OF TRIMETHYLAMINE N-OXIDE, A RISK FACTERS FOR CARDIOVASCULAR COMPLICATIONS18
WCN26-2291 Depletion of gut microbiota alleviates proteinuria in puromycin aminonucleoside-induced nephrosis in rats18
WCN26-9481 SURVEY OF HERPES ZOSTER IN KIDNEY TRANSPLANT PATIENTS: A SINGLE-CENTER STUDY17
WCN26-4681 CLINICAL CHARACTERISTICS OF TUBULOINTERSTITIAL NEPHRITIS WITH GLYCOSURIA: A RETROSPECTIVE OBSERVATIONAL STUDY17
WCN26-5688 SUCCESSFUL PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY FOR CHRONIC LEFT SUBCLAVIAN VEIN OCCLUSION UTILIZING BIPLANE ANGIOGRAPHY AND INTRAVASCULAR ULTRASOUND: A CASE STUDY17
WCN26-1763 Outcomes of pre-dialysis education on chronic kidney disease patients17
WCN26-2141 COMPARISON OF RESIDENT VERSUS PROGRAM DIRECTOR PERSPECTIVES ON RESIDENT SPECIALTY SELECTION17
WCN26-5202 FACTORS ASSOCIATED MORTALITY OF ADULTS PATIENTS HOSPITALIZED WITH ACUTE KIDNEY INJURY : SINGLE CENTER STUDY AT REGIONAL REFERENCE CENTER17
WCN26-6962 IMMUNOADSORPTION (IA) AND ENDOCARDITIS IN END STAGE RENAL DISEASE (ESRD) PATIENTS17
WCN26-3170 PERFORMANCE OF REASONING MODELS ON NEPHROLOGY MULTIPLE-CHOICE QUESTIONS17
WCN26-7845 EDEMA BEYOND PROTEINURIA: CLINICOPATHOLOGIC CORRELATES AND HISTOPATHOLOGIC SPECTRUM OF LUPUS NEPHRITIS WITH NEPHROTIC AND NON-NEPHROTIC RANGE PROTEINURIA17
WCN26-3558 DIVERSE PHENOTYPIC EXPRESSIONS OF COL4A4 MUTATIONS: A CASE OF NEPHROTIC SYNDROME PRESENTING AS FSGS17
WCN26-6499 ACETYLCHOLINE SIGNALING IN RENAL MACROPHAGES CONTRIBUTES TO HYPERTENSION DEVELOPMENT17
WCN26-3766 IN-HOSPITAL OUTCOMES AND MORTALITY PREDICTORS IN CHRONIC KIDNEY DISEASE PATIENTS IN RESOURCE-LIMITED SETTINGS: A CASE STUDY FROM A TERTIARY HOSPITAL IN TANZANIA17
WCN26-6234 TRANSFORMING CRITICAL CARE FOR RENAL PATIENTS IN RESOURCE-LIMITED SETTINGS: THE IMPACT OF ICU EXPANSION AT KIDNEY FOUNDATION HOSPITAL AND RESEARCH INSTITUTE, BANGLADESH17
WCN26-3778 MECHANISTIC EFFECTS OF SEMAGLUTIDE ON KIDNEY DISEASE IN TYPE 2 DIABETES: THE REMODEL TRIAL17
WCN26-6838 Beyond Diabetic Kidney Disease: Histopathological Spectrum and Clinical Outcomes of Renal Biopsy in Patients with Diabetes Mellitus17
WCN26-7337 LEAN TISSUE INDEX TRAJECTORIES AND OUTCOMES AMONG SINGAPORE’S INCIDENT HEMODIALYSIS PATIENTS17
WCN26-3040 EXPLORING HYPERURICEMIA-INDEPENDENT PROTEIN CONTRIBUTORS TO GOUT USING PUBLICLY AVAILABLE GENOMIC DATA17
WCN26-8852 Optimizing Neonatal AKI Diagnosis: Which Criteria Best Predict Clinical Outcomes?17
WCN26-6415 ASSOCIATION OF LOW SERUM 25-HYDROXYVITAMIN D WITH ARTERIAL STIFFNESS IN NON-DIALYSIS CKD (STAGE 3-5)17
WCN26-7165 A case of acute transient distal renal tubular acidosis and Fanconi syndrome with adenovirus infection: A new etiology of type 3 renal tubular acidosis17
WCN26-5473 Heterogeneous reno-protective effects of hypoxia-inducible factor prolyl hydroxylase inhibitors versus erythropoietin-stimulating agents in kidney dysfunction: a target trial emulation with17
WCN26-8528 FERRIC CARBOXYMALTOSE VERSUS FERRIC DERISOMALTOSE: IMPACT ON HYPOPHOSPHATEMIA - A CASE REPORT17
WCN26-3163 Effect of PROtein-calorie MalnutritiOn on clinical ouTcomEs in AKI patients on CRRT: A secondary analysis of a prospective cohort study (PROMOTE-CRRT)17
WCN26-5264 Long-Term Prognosis of Adenine phosphoribosyltransferase Deficiency in Japanese: A Literature Review16
WCN26-7924 ROLE OF GDF15 IN LITHIUM-INDUCED COLLECTING DUCT REMODELING16
Clinical and Genetic Insights Into Isolated Proteinuria With CUBN Variants16
WCN26-1186 UNBOXING A RARE LINK BETWEEN THE KIDNEYS AND THE LUNGS: REVERSAL OF INFECTION RELATED GLOMERULONEPHRITIS IN A PEDIATRIC PULMONARY TUBERCULOSIS PATIENT WITH CORTICOSTEROIDS16
WCN26-6032 CAUSAL EFFECTS OF LIFESTYLE AND DIET ON URINARY STONES: FROM GENETIC INSIGHTS TO POPULATION-BASED EVIDENCE16
WCN26-161 CUTANEOUS MANIFESTATIONS IN RENAL TRANSPLANT RECIPENTS: A SINGLE CENTER, CROSS-SECTIONAL STUIDY IN THAILAND16
WCN26-2911 DETERMINING OPTIMAL STRATEGY EMPLOYING ANTITHYMOCYTE GLOBULIN (DOSE-ATG) AS INDUCTION THERAPY AMONG FILIPINO KIDNEY TRANSPLANT RECIPIENTS: A RETROSPECTIVE COHORT16
WCN26-7623 CLAUDIN-1 INHIBITOR AMELIORATES DIABETIC KIDNEY DISEASE BY SUPPRESSING SRC/AKT/MTOR SIGNALING PATHWAY16
WCN23-0159 ENPP6 IS A POTENTIAL NOVEL CANDIDATE GENE FOR MONOGENIC CONGENITAL ANOMALIES OF THE KIDNEYS AND URINARY TRACT16
WCN26-4464 Preliminary study of multiparametric MRI in diagnosing acute kidney injury and chronic kidney disease without creatinine baseline in 3 months16
WCN26-7166 RELAPSE OF REFRACTORY NEPHROTIC SYNDROME BY VACCINATION SHORTLY AFTER RECOVERY FROM COVID-19 RESULTING IN BILATERAL ACHILLES TENDON RUPTURE:A CASE REPORT16
WCN26-4069 EFFICACY AND SAFETY OF IPTACOPAN IN PARTICIPANTS WITH C3 GLOMERULOPATHY: C3G EXTENSION TRIAL INTERIM RESULTS FROM THE PHASE 3 APPEAR-C3G PARTICIPANTS16
Belatacept Conversion in Adolescent Kidney Transplant Recipients: A Solution for the Critical Challenge of Adherence?16
WCN26-5646 PATHOLOGICAL AND CLINICAL FEATURES OF KIDNEY LESIONS IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE16
Fertility Management in Cystinosis: A Clinical Perspective16
WCN26-9430 CAUSAL PATHWAYS LINKING GUT MICROBIOTA, METABOLITES, AND DIABETIC NEPHROPATHY: A MENDELIAN RANDOMIZATION STUDY16
WCN26-7273 Features of Cardiorenal Interactions in Patients with Сoronary Artery Disease and Renal Artery Stenosis16
WCN25-4586 Microbiological Evaluation of Urinary samples in A Cohort of Patients with Chronic Kidney Disease: A descriptive study15
Exploring Preconceptions as Barriers to Peritoneal Dialysis Eligibility: A Global Scenario-Based Survey of Kidney Care Physicians15
Genetically Predicted Body Selenium Concentration and estimated GFR: A Mendelian Randomization Study15
WCN24-861 SUBCLINICAL RHABDOMYOLYSIS IN MESOAMERICAN NEPHROPATHY15
WCN23-0427 COENZYME Q10 SUPPLEMENTATION IN AN ADULT PATIENT WITH COQ8 MUTATION AND NEPHROTIC SYNDROME ALLEVIATES RENAL FUNCTION DETERIORATION AND REMITS PROTEINURIA15
Clinical Real-Time Genome Sequencing to Solve the Complex and Confounded Presentation of a Child With Focal Segmental Glomerulosclerosis and Multiple Malignancies15
Allogeneic CD4 T Cells Sustain Effective BK Polyomavirus-Specific CD8 T Cell Response in Kidney Transplant Recipients15
WCN25-1682 STUDY OF MEAN PLATELET VOLUME AND RED CELL DISTRIBUTION WIDTH IN ACUTE KIDNEY INJURY15
Corrigendum to “WCN24-2221 NEPHROCALCINOSIS AND LOWER LIMBS TISSUE NECROSIS DUE TO CALCIUM OXALATE DEPOSITS IN A 24-YEAR-OLD PATIENT WITH STAGE 5 CHRONIC KIDNEY DISEASE” [Kidney International Reports 15
Corrigendum to “Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy” [Kidney International Reports Volume 6, Issue 4, April 2021, Pages 1183-1188]15
WCN24-1506 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY: INTERIM RESULTS FROM THE PHASE 3 APPLAUSE-IgAN STUDY15
Frequency and Outcomes of Kidney Replacement Therapy Transitions in Canada15
Biomarkers of Kidney Tubule Disease and Risk of End-Stage Kidney Disease in Persons With Diabetes and CKD15
Errata15
Erratum to “Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement Inhibition” [Kidney International Reports Volume 9, Issue 4, April 2024, Pages 91915
Corrigendum to “Clinicopathological Characteristics of Adult IgA Nephropathy in the United States” [Kidney International Reports Volume 8, Issue 9, September 2023, Pages 1792-1800]15
Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Antibody-Associated Renal Vasculitis and Concominant Complement System Activation15
WCN24-1204 MULTIDIMENSIONAL BURDEN OF CHRONIC KIDNEY DISEASE IN EIGHT COUNTRIES: INSIGHTS FROM THE IMPACT CKD STUDY15
Dissecting the Obesity Paradox in Patients With Obesity and CKD15
Oxidative Stress Contributes to Slit Diaphragm Defects Caused by Disruption of Endocytosis15
Use of Glucose-Lowering Agents in Diabetes and CKD14
From Hub to Spokes: Expanding Equitable Dialysis Care in the State of Telangana14
WCN24-455 COMMUNITY HEALTH WORKERS AND CHRONIC KIDNEY DISEASE: A GLOBAL PERSPECTIVE14
Dried Blood Spot Sampling for Monitoring Children With Immune-Mediated Glomerulopathies and After Kidney Transplantation14
Atypical Anti–Glomerular Basement Membrane Disease14
Long-term Outcome of Adult Patients With Membranous Nephropathy Treated With Rituximab14
Canadian Stakeholders’ Perspectives on Voucher Donation in Kidney Transplantation14
Living with Atypical Hemolytic Uremic Syndrome in the Netherlands: Patient and Family Perspective14
Cardiac-Gated Diffusion-Weighted Magnetic Resonance Imaging Assessment of Kidney Function in Patients With Kidney Cancer14
Systematic Review of the Effects of Iron on Cardiovascular, Kidney, and Safety Outcomes in Patients With CKD14
Defining Relationships Among Tests for Kidney Transplant Antibody-Mediated Rejection14
Identification of Glomerular and Plasma Apolipoprotein M as Novel Biomarkers in Glomerular Disease14
POS-140 DEVELOPMENT OF CHRONIC KIDNEY DISEASE FROM SNAKE BITE INDUCED ACUTE KIDNEY INJURY- RISK ASSESSMENT14
Torque Teno Virus-Guided Immunosuppression in Kidney Transplantation: Expanding the Application14
POS-003 The three C-terminal domains of FHR1 influence complement activation and FHR1 cooperation with other complement regulators14
Hydralazine–Isosorbide Dinitrate Use in Patients With End-Stage Kidney Disease on Dialysis14
Systematic Review of IgA Nephropathy Coexisting With Alport Syndrome14
Metabolic Acidosis Is Associated With an Accelerated Decline of Allograft Function in Pediatric Kidney Transplantation14
POS-001 Mitochondrial enzymes infused into the kidney under hydrodynamic pressures significantly improves creatinine and BUN levels at the onset of moderate and severe acute kidney injuries14
Clinicopathologic Features of IgG4-Related Kidney Disease14
Projecting the Population Level Burden of CKD Progression According to Urine Albumin-to-Creatinine Ratio Categories13
Longitudinal Changes in Kidney Solute Clearance in a Prospective Cohort of Patients Initiating Chronic Hemodialysis13
The Weight of Disease, the Loss Within: Rethinking Frailty Assessment in ADPKD13
Ecological Momentary Assessment to Explore Fatigue, Mood, and Physical Activity Levels in People Receiving Peritoneal Dialysis13
WCN24-1712 EPIDEMIOLOGICAL ANALYSIS OF MORTALITY FROM URINARY TRACT MALIGNANT NEOPLASM IN BRAZIL, 2010 - 202013
WCN24-1323 TO DETERMINE THE EFFICACY OF LACTOFERRIN IN IMPROVING HEMOGLOBIN LEVELS IN CHRONIC KIDNEY DISEASE PATIENTS WITH IRON DEFICIENCY ANEMIA13
Framework for Apolipoprotein 1-Mediated Kidney Disease Classification13
Higher Symptom Frequency and Severity After the Long Interdialytic Interval in Patients on Maintenance Intermittent Hemodialysis13
Kidney Volume and Molecular Processes are Dynamic in ADPKD13
Cost-Minimization Analysis of Tolvaptan Treatment for ADPKD in Southern Spain13
WCN24-1687 Factors associated with partial or total recovery of renal function in patients with AKI KDIGO 3 at the ISSEMyM Medical Center who required replacement therapy13
Early Identification of CKD—A Scoping Review of the Global Populations13
High Macrophage Densities in Native Kidney Biopsies Correlate With Renal Dysfunction and Promote ESRD13
Evaluating Sibeprenlimab in IgA Nephropathy - Rationale and Baseline Data from the VISIONARY Trial13
Population Frequency of Undiagnosed Fabry Disease in the General Population13
WCN25-79 NON-INVASIVE DIAGNOSIS OF CHRONIC KIDNEY DISEASE BY MACHINE-LEARNING BASED EVALUATION OF URINARY EXFOLIATED PROXIMAL TUBULE CELL MULTISPECTRAL AUTOFLUORESCENCE13
WCN24-2140 KNOWLEDGE, AWARENESS AND ATTITUDE TOWARDS ORGAN DONATION AMONG GENERAL POPULATION IN INDIA: A SINGLE CENTRE EXPERIENCE13
WCN25-977 A SPECTRUM OF KIDNEY DISEASES IN CHILDREN WITH POLYGLANDULAR AUTOIMMUNE SYNDROME TYPE 112
0.13206505775452